Beacon Financial Group Abbott Laboratories Transaction History

Beacon Financial Group

  • $886 Million
  • Q4 2024

A detailed history of Beacon Financial Group transactions in Abbott Laboratories stock. As of the latest transaction made, Beacon Financial Group holds 9,456 shares of ABT stock, worth $1.24 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
9,456
Previous 9,468 0.13%
Holding current value
$1.24 Million
Previous $1.08 Million 0.93%
% of portfolio
0.12%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$111.93 - $119.39 $1,343 - $1,432
-12 Reduced 0.13%
9,456 $1.07 Million
Q3 2024

Nov 12, 2024
BUY
$100.07 - $118.13 $34,123 - $40,282
341 Added 3.74%
9,468 $1.08 Million
Q2 2024

Aug 06, 2024
SELL
$100.73 - $112.44 $15,109 - $16,866
-150 Reduced 1.62%
9,127 $948,000
Q1 2024

May 07, 2024
SELL
$109.52 - $120.96 $57,169 - $63,141
-522 Reduced 5.33%
9,277 $1.05 Million
Q4 2023

Feb 23, 2024
SELL
$90.19 - $110.4 $2,705 - $3,312
-30 Reduced 0.31%
9,799 $1.08 Million
Q3 2023

Oct 16, 2023
SELL
$95.53 - $114.62 $20,634 - $24,757
-216 Reduced 2.15%
9,829 $1.01 Million
Q2 2023

Jul 20, 2023
SELL
$100.78 - $112.29 $49,281 - $54,909
-489 Reduced 4.64%
10,045 $1.08 Million
Q1 2023

Apr 14, 2023
SELL
$96.86 - $114.01 $289,030 - $340,205
-2,984 Reduced 22.07%
10,534 $1.09 Million
Q4 2022

Jan 19, 2023
BUY
$95.06 - $111.52 $16,350 - $19,181
172 Added 1.29%
13,518 $1.48 Million
Q3 2022

Oct 13, 2022
SELL
$96.76 - $112.03 $967 - $1,120
-10 Reduced 0.07%
13,346 $1.31 Million
Q2 2022

Jul 19, 2022
BUY
$102.07 - $123.37 $5,409 - $6,538
53 Added 0.4%
13,356 $1.44 Million
Q1 2022

Apr 08, 2022
BUY
$114.02 - $139.04 $13,226 - $16,128
116 Added 0.88%
13,303 $1.6 Million
Q4 2021

Jan 07, 2022
BUY
$115.53 - $141.46 $5,083 - $6,224
44 Added 0.33%
13,187 $1.83 Million
Q3 2021

Oct 13, 2021
BUY
$116.66 - $129.06 $119,109 - $131,770
1,021 Added 8.42%
13,143 $1.57 Million
Q2 2021

Jul 26, 2021
BUY
$105.79 - $124.53 $42,950 - $50,559
406 Added 3.47%
12,122 $1.44 Million
Q4 2020

Jan 15, 2021
SELL
$105.0 - $114.42 $52,395 - $57,095
-499 Reduced 4.09%
11,716 $1.3 Million
Q3 2020

Oct 13, 2020
SELL
$91.64 - $111.29 $63,323 - $76,901
-691 Reduced 5.35%
12,215 $1.33 Million
Q2 2020

Aug 05, 2020
BUY
$76.57 - $98.0 $918 - $1,176
12 Added 0.09%
12,906 $1.15 Million
Q1 2020

Jun 29, 2020
SELL
$62.82 - $91.86 $15,579 - $22,781
-248 Reduced 1.89%
12,894 $1.02 Million
Q4 2019

Jan 17, 2020
BUY
$78.51 - $87.4 $152,544 - $169,818
1,943 Added 17.35%
13,142 $1.14 Million
Q3 2019

Oct 15, 2019
SELL
$81.84 - $88.74 $8,756 - $9,495
-107 Reduced 0.95%
11,199 $917,000
Q2 2019

Jul 15, 2019
SELL
$72.88 - $85.0 $874 - $1,020
-12 Reduced 0.11%
11,306 $951,000
Q1 2019

Apr 18, 2019
SELL
$66.22 - $80.06 $526,647 - $636,717
-7,953 Reduced 41.27%
11,318 $905,000
Q4 2018

Jan 16, 2019
SELL
$65.56 - $74.27 $77,623 - $87,935
-1,184 Reduced 5.79%
19,271 $1.37 Million
Q3 2018

Oct 10, 2018
SELL
$60.81 - $73.36 $39,404 - $47,537
-648 Reduced 3.07%
20,455 $1.5 Million
Q2 2018

Jul 11, 2018
SELL
$57.57 - $63.54 $80,770 - $89,146
-1,403 Reduced 6.23%
21,103 $1.29 Million
Q1 2018

Apr 06, 2018
SELL
$56.27 - $63.62 $84,686 - $95,748
-1,505 Reduced 6.27%
22,506 $1.35 Million
Q4 2017

Jan 03, 2018
BUY
$53.68 - $57.47 $63,235 - $67,699
1,178 Added 5.16%
24,011 $1.37 Million
Q3 2017

Oct 03, 2017
BUY
$48.06 - $53.64 $1.1 Million - $1.22 Million
22,833
22,833 $1.22 Million

Others Institutions Holding ABT

# of Institutions
3,247
Shares Held
1.31B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $230B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Beacon Financial Group Portfolio

Follow Beacon Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email